Biodesix at TPD Summit 2026

Oct 26–29, 2026 Boston, MA ~300 attendees Website

Biodesix takes part in 1 session at TPD Summit 2026 in Boston. Its talk covers developing a KIF22 pharmacodynamic biomarker that measures target degradation in blood cells, for use in clinical studies.

OrganizationTPD Summit 2026 Attendance
Biodesix
Louisville, CO
◇Program Partner
biodesix.com
CROs & CDMOsProgram Partner
Lung disease diagnostics company with Medicare-covered tests that offers biopharma partners biomarker development and laboratory testing services.
Talk
Tue Oct 27
12:00pm
Measuring Target Degradation in Peripheral Blood Mononuclear Cells: Development of a KIF22 Pharmacodynamic Biomarker for the Clinic
Track C: Translational & Clinical Development

Explore the full TPD Summit 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full TPD Summit 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Biodesix

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the TPD & Induced Proximity Summit or its organizers. Submit a correction